Our Pipeline
Boosting cell therapies against solid tumors
We are continually working to develop and efficiently move our products through regulatory requirements and clinical testing. Our platform’s modular nature and application flexibility has allowed us to develop multiple commercialization avenues, focusing on both Pediatric and Adult Cancers..
Benefits of including the CTSR technology in an in-vivo Pancreatic Tumor System
B7H3 CAR T cells perform poorly in this pancreatic cell xenograft system but
the inclusion of the CTSR module dramatically improves survival.